Kv1.3 inhibition with ShK suppress cytokine production, inhibits proliferation of TEM cells and ameliorates disease manifestation in animal models of delayed type hypersensitivity, T1DM, RA and MS [71]. This evidence concerns the gene KCNA3 and type 1 diabetes mellitus.